Indication

For treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults

Medicine details

Medicine name:
hydrocortisone modified-release hard capsules (Efmody)
SMC ID:
SMC2414
Pharmaceutical company
Diurnal Limited
BNF chapter
Endocrine system
Submission type
Full
Publication due date:
14 March 2022
SMC meeting date:
01 February 2022
Patient group submission deadline:
29 November 2021